Magnus Medical has hired Timothy Hale as VP of marketing.
Hale arrives with more than 20 years of medical device and pharmaceutical industry experience. Previously, he was senior director of global marketing for AngioDynamics, where he led the commercial launch of its laser atherectomy system. Before that, Hale worked at Neuronetics, Boehringer Ingelheim and Forest Pharmaceuticals.
In October, the U.S. Food & Drug Administration granted Magnus breakthrough device designation for its brain stimulation technology designed to treat adults suffering from major depressive disorder (MDD) in people who have not improved sufficiently from antidepressant medication or other treatments. At the time, Magnus also announced $25 million in series A financing co-led by Jazz Venture Partners and Red Tree Venture Capital.
